A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery. The United Nations Convention on Biological Diversity defines 'biotechnology' as: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use."[1] In other words, biotechology can be defined as the mere application of technical advances in life science to develop commercial products. Today, no comprehensive global database of biotech companies is available online, despite the fact that a free and open access project was launched in late 2014.[2]
Independent biotechnology companies
- The following is a list of the top 25 independent biotechnology companies listed on a stock exchange ranked by Market Capitalization as of June 2015 (Q2 2015).
- Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups - such as Genentech (owned by Roche), Genzyme (Sanofi), or MedImmune (AstraZeneca).
Rank | Change | Company | Country | Highest Market Cap ever (historical)(USD billions) | Market Cap in Q2 2015 (USD billions)[3] | Market Cap in 2014 (USD billions)[4] | Market Cap in 2013 (USD billions) |
---|---|---|---|---|---|---|---|
1 | ![]() |
Johnson & Johnson | USA | 306.4 September 2014 |
276.9 | 277.8 | 258.3 |
2 | ![]() |
Novartis | SUI | 275.2 July 2015 |
272.6 | 229.8 | 195.0 |
3 | ![]() |
Roche | SUI | 263.6 February 2014 |
240.4 | 258.5 | 240.3 |
4 | ![]() |
Pfizer | USA | 310.5 July 2000 |
211.7 | 205.4 | 196.0 |
5 | ![]() |
Merck | USA | 178.9 January 2015 |
162.3 | 166.9 | 146.5 |
6 | ![]() |
Novo Nordisk | DEN | 153.8 June 2015 |
147.0 | 125.4 | 19.6 |
7 | ![]() |
Gilead Sciences | USA | 179.6 June 2013 |
145.1 | 109.0 | 78.4 |
8 | ![]() |
Sanofi | FRA | 151.3 September 2014 |
136.0 | 138.1 | 142.0 |
9 | ![]() |
Amgen | USA | 130.6 December 2014 |
117.7 | 93.1 | 78.7 |
10 | ![]() |
Allergan | USA | 122.6 July 2015 |
116.7 | 38.2 | 15.0 |
11 | ![]() |
GlaxoSmithKline | GBR | 174.9 May 2006 |
114.1 | 128.9 | 129.6 |
12 | ![]() |
Bayer | GBR | 129 March 2015 |
111.2 | 113.2 | 117.4 |
13 | ![]() |
Bristol-Myers Squibb | USA | 115.3 May 2015 |
105.0 | 97.6 | 87.2 |
14 | ![]() |
Biogen Idec | USA | 111.7 March 2015 |
97.0 | 79.7 | 66.1 |
15 | ![]() |
AbbVie | USA | 112.2 June 2015 |
91.7 | 104.1 | 83.8 |
16 | ![]() |
Celgene | USA | 102.9 March 2015 |
90.4 | 89.5 | 69.2 |
17 | ![]() |
AstraZeneca | GBR | 102.9 October 2006 |
87.7 | 88.9 | 74.6 |
18 | ![]() |
Eli Lilly & Co | USA | 122.6 August 2000 |
79.2 | 76.6 | 57.0 |
19 | ![]() |
Abbott Laboratories | USA | 74.8 July 2015 |
69.9 | 67.9 | 59.3 |
20 | ![]() |
Valeant Pharmaceuticals | CAN | 82.8 May 2015 |
67.7 | 47.9 | 39.1 |
21 | ![]() |
Teva Pharmaceutical | ISR | 58.9 April 2010 |
54.5 | 49.0 | 37.8 |
22 | ![]() |
Regeneron Pharmaceuticals Inc | USA | 55.7 June 2015 |
54.3 | 42.0 | 27.4 |
23 | ![]() |
Shire Pharmaceuticals | IRL | 52.4 October 2014 |
49.8 | 42.4 | 28.1 |
24 | ![]() |
Alexion Pharmaceuticals | USA | 43.1 June 2015 |
43.5 | 36.8 | 26.2 |
25 | ![]() |
Mylan | NED | 37.2 April 2015 |
34.9 | 21.2 | 16.1 |
References
- ^ "The Convention on Biological Diversity (Article 2. Use of Terms)." United Nations. 1992. Retrieved on February 6, 2008.
- ^ Carlo Alberto Oppici, Filippo Giancarlo Martinelli. "BioDirecta". Retrieved 22 March 2015.
- ^ http://www.forbes.com/global2000/list/#header:marketValue_sortreverse:true_industry:Pharmaceuticals
- ^ http://www.statista.com/statistics/272716/global-top-biotech-and-pharmaceutical-companies-based-on-market-value/
External links
- BioPharmGuy: Biotech database established in 2008. Sortable by location or business type
- Another List of Biotechnology Companies
- BioDirecta: the most comprehensive free database of biotech and pharma companies
|
|